redecol_UK

We change the world of #lung #monitoring:
#asthma #COPD #COVID19

🧭 +4 years R&D
🏦 +1 Mio GBP Funding
🥇InnovateUK grants
🏥 NHS network
§ Patents

[redecol_UK @redecol_UK]

Redecol Limited’s board appoints Hyman Capital as advisor to its fund raising activities.

#BreathEasyFlow, a novel medical device for measuring #lunghealth. #JustBreath

#Asthma #COPD #Innovation #LongCovid #LongCovidKids #lung #AsthmaUK #asthmaticsatrisk #InnovateUK #Funding

[redecol_UK @redecol_UK]

@critcarerecover @POWERbreatheUK @LifeLines_ICU @ICUsteps Our success - What others says:

"The device uses a novel approach based on the exhaled breath condensate breath profile and [...] data suggests [...] great value to the management of the asthma patient in the home"

Prof A. Wardlaw, Head of Respiratory Medicine, Leicester (2018)

[redecol_UK @redecol_UK]

@MDT_RMS_EMEA @medtecheurope Our success - What others says:

"The device uses a novel approach based on the exhaled breath condensate breath profile and [...] data suggests [...] great value to the management of the asthma patient in the home"

Prof A. Wardlaw, Head of Respiratory Medicine, Leicester (2018)

[redecol_UK @redecol_UK]

@MDT_RMS_EMEA Our success - What others says:

"The device uses a novel approach based on the exhaled breath condensate breath profile and [...] data suggests [...] great value to the management of the asthma patient in the home"

Prof A. Wardlaw, Head of Respiratory Medicine, Leicester (2018)

[redecol_UK @redecol_UK]

@MDT_RMS_EMEA @medtecheurope Our success - What others says:

"The device uses a novel approach based on the exhaled breath condensate breath profile and [...] data suggests [...] great value to the management of the asthma patient in the home"

Prof A. Wardlaw, Head of Respiratory Medicine, Leicester (2018)

[redecol_UK @redecol_UK]

@MDT_RMS_EMEA Our success - What others says:

"The device uses a novel approach based on the exhaled breath condensate breath profile and [...] data suggests [...] great value to the management of the asthma patient in the home"

Prof A. Wardlaw, Head of Respiratory Medicine, Leicester (2018)

[redecol_UK @redecol_UK]

@MDT_RMS_EMEA Our success - What others says:

"The device uses a novel approach based on the exhaled breath condensate breath profile and [...] data suggests [...] great value to the management of the asthma patient in the home"

Prof A. Wardlaw, Head of Respiratory Medicine, Leicester (2018)

[redecol_UK @redecol_UK]

@MDT_RMS_EMEA What others says:

"[...] newer technologies [...] such as BreathEasyFlow have tremendous potential to inform initial diagnosis and ongoing self management, and support clinician decision making."

Dr. John Blakey, Former Respiratory Lead for the NIHR Clinical Research Network

[redecol_UK @redecol_UK]

@MDT_RMS_EMEA @medtecheurope What others says:

"[...] newer technologies [...] such as BreathEasyFlow have tremendous potential to inform initial diagnosis and ongoing self management, and support clinician decision making."

Dr. John Blakey, Former Respiratory Lead for the NIHR Clinical Research Network

[redecol_UK @redecol_UK]

@medtecheurope What others says:

"[...] newer technologies [...] such as BreathEasyFlow have tremendous potential to inform initial diagnosis and ongoing self management, and support clinician decision making."

Dr. John Blakey, Former Respiratory Lead for the NIHR Clinical Research Network

[redecol_UK @redecol_UK]

@Fundpfizer_ES @medtecheurope @fenin_es @isanidad What others says:

"[...] newer technologies [...] such as BreathEasyFlow have tremendous potential to inform initial diagnosis and ongoing self management, and support clinician decision making."

Dr. John Blakey, Former Respiratory Lead for the NIHR Clinical Research Network

[redecol_UK @redecol_UK]

@JNJMedDeviceUKI @medtecheurope @CERENOVUS_HQ What others says:

"[...] newer technologies [...] such as BreathEasyFlow have tremendous potential to inform initial diagnosis and ongoing self management, and support clinician decision making."

Dr. John Blakey, Former Respiratory Lead for the NIHR Clinical Research Network

[redecol_UK @redecol_UK]

@KalinaBozhkova @medtecheurope What others says:

"[...] newer technologies [...] such as BreathEasyFlow have tremendous potential to inform initial diagnosis and ongoing self management, and support clinician decision making."

Dr. John Blakey, Former Respiratory Lead for the NIHR Clinical Research Network

[redecol_UK @redecol_UK]

@medtecheurope What others says:

"[...] newer technologies [...] such as BreathEasyFlow have tremendous potential to inform initial diagnosis and ongoing self management, and support clinician decision making."

Dr. John Blakey, Former Respiratory Lead for the NIHR Clinical Research Network

[redecol_UK @redecol_UK]

@ResMedEurope @medtecheurope What others says:

"[...] newer technologies [...] such as BreathEasyFlow have tremendous potential to inform initial diagnosis and ongoing self management, and support clinician decision making."

Dr. John Blakey, Former Respiratory Lead for the NIHR Clinical Research Network

[redecol_UK @redecol_UK]

@medtecheurope What others says:

"[...] newer technologies [...] such as BreathEasyFlow have tremendous potential to inform initial diagnosis and ongoing self management, and support clinician decision making."

Dr. John Blakey, Former Respiratory Lead for the NIHR Clinical Research Network

[redecol_UK @redecol_UK]

@medtecheurope @ESIP_EU @PCHAlliance @UEHP_Brux @AIM_Healthcare @euhospitals What others says:

"[...] newer technologies [...] such as BreathEasyFlow have tremendous potential to inform initial diagnosis and ongoing self management, and support clinician decision making."

Dr. John Blakey, Former Respiratory Lead for the NIHR Clinical Research Network

[redecol_UK @redecol_UK]

@medtecheurope What others says:

"[...] newer technologies [...] such as BreathEasyFlow have tremendous potential to inform initial diagnosis and ongoing self management, and support clinician decision making."

Dr. John Blakey, Former Respiratory Lead for the NIHR Clinical Research Network

[redecol_UK @redecol_UK]

@CookMedicalEU @medtecheurope What others says:

"[...] newer technologies [...] such as BreathEasyFlow have tremendous potential to inform initial diagnosis and ongoing self management, and support clinician decision making."

Dr. John Blakey, Former Respiratory Lead for the NIHR Clinical Research Network

[redecol_UK @redecol_UK]

@MedtronicFR @medtecheurope What others says:

"[...] newer technologies [...] such as BreathEasyFlow have tremendous potential to inform initial diagnosis and ongoing self management, and support clinician decision making."

Dr. John Blakey, Former Respiratory Lead for the NIHR Clinical Research Network